370 related articles for article (PubMed ID: 34321005)
1. Usefulness of the triglyceride glucose-body mass index in evaluating nonalcoholic fatty liver disease: insights from a general population.
Wang R; Dai L; Zhong Y; Xie G
Lipids Health Dis; 2021 Jul; 20(1):77. PubMed ID: 34321005
[TBL] [Abstract][Full Text] [Related]
2. Triglyceride Glucose Index and Related Parameters (Triglyceride Glucose-Body Mass Index and Triglyceride Glucose-Waist Circumference) Identify Nonalcoholic Fatty Liver and Liver Fibrosis in Individuals with Overweight/Obesity.
Khamseh ME; Malek M; Abbasi R; Taheri H; Lahouti M; Alaei-Shahmiri F
Metab Syndr Relat Disord; 2021 Apr; 19(3):167-173. PubMed ID: 33259744
[No Abstract] [Full Text] [Related]
3. Association between triglyceride glucose-body mass index and non-alcoholic fatty liver disease in the non-obese Chinese population with normal blood lipid levels: a secondary analysis based on a prospective cohort study.
Li Y; Zheng R; Li J; Feng S; Wang L; Huang Z
Lipids Health Dis; 2020 Oct; 19(1):229. PubMed ID: 33109219
[TBL] [Abstract][Full Text] [Related]
4. The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population.
Hu H; Han Y; Cao C; He Y
J Transl Med; 2022 Sep; 20(1):398. PubMed ID: 36064712
[TBL] [Abstract][Full Text] [Related]
5. The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease.
Sheng G; Lu S; Xie Q; Peng N; Kuang M; Zou Y
Lipids Health Dis; 2021 Oct; 20(1):134. PubMed ID: 34629059
[TBL] [Abstract][Full Text] [Related]
6. The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease.
Zhang S; Du T; Zhang J; Lu H; Lin X; Xie J; Yang Y; Yu X
Lipids Health Dis; 2017 Jan; 16(1):15. PubMed ID: 28103934
[TBL] [Abstract][Full Text] [Related]
7. Triglyceride glucose-body mass index is effective in identifying nonalcoholic fatty liver disease in nonobese subjects.
Zhang S; Du T; Li M; Jia J; Lu H; Lin X; Yu X
Medicine (Baltimore); 2017 Jun; 96(22):e7041. PubMed ID: 28562560
[TBL] [Abstract][Full Text] [Related]
8. Triglyceride glucose-waist circumference: the optimum index to screen nonalcoholic fatty liver disease in non-obese adults.
Li S; Feng L; Ding J; Zhou W; Yuan T; Mao J
BMC Gastroenterol; 2023 Nov; 23(1):376. PubMed ID: 37919650
[TBL] [Abstract][Full Text] [Related]
9. Utility of Indices Obtained during Medical Checkups for Predicting Fatty Liver Disease in Non-obese People.
Otsubo N; Fukuda T; Cho G; Ishibashi F; Yamada T; Monzen K
Intern Med; 2023 Aug; 62(16):2307-2319. PubMed ID: 36517035
[TBL] [Abstract][Full Text] [Related]
10. Value of the triglyceride glucose index combined with body mass index in identifying non-alcoholic fatty liver disease in patients with type 2 diabetes.
Li N; Tan H; Xie A; Li C; Fu X; Xang W; Kirim A; Huang X
BMC Endocr Disord; 2022 Apr; 22(1):101. PubMed ID: 35428219
[TBL] [Abstract][Full Text] [Related]
11. Triglyceride Glucose Index Is Superior to the Homeostasis Model Assessment of Insulin Resistance for Predicting Nonalcoholic Fatty Liver Disease in Korean Adults.
Lee SB; Kim MK; Kang S; Park K; Kim JH; Baik SJ; Nam JS; Ahn CW; Park JS
Endocrinol Metab (Seoul); 2019 Jun; 34(2):179-186. PubMed ID: 31257745
[TBL] [Abstract][Full Text] [Related]
12. Non-alcoholic fatty liver disease in Tanzania: prevalence, determinants, and diagnostic performance of triglycerides-glucose index and triglycerides-glucose index -body mass index compared to the hepatic ultrasound in overweight and obese individuals.
Kilonzo SB; Kamala E; Jaka H; Ngoya P
BMC Gastroenterol; 2024 Mar; 24(1):96. PubMed ID: 38438930
[TBL] [Abstract][Full Text] [Related]
13. The triglyceride-glucose index is associated with the severity of hepatic steatosis and the presence of liver fibrosis in non-alcoholic fatty liver disease: a cross-sectional study in Chinese adults.
Guo W; Lu J; Qin P; Li X; Zhu W; Wu J; Xu N; Zhang Q
Lipids Health Dis; 2020 Oct; 19(1):218. PubMed ID: 33028338
[TBL] [Abstract][Full Text] [Related]
14. Correlation between triglyceride glucose-body mass index and hypertension risk: evidence from a cross-sectional study with 60,283 adults in eastern China.
Chen Y; Du J; Zhou N; Song Y; Wang W; Hong X
BMC Cardiovasc Disord; 2024 May; 24(1):270. PubMed ID: 38783200
[TBL] [Abstract][Full Text] [Related]
15. The Triglyceride and Glucose Index Is a Predictor of Incident Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study.
Kitae A; Hashimoto Y; Hamaguchi M; Obora A; Kojima T; Fukui M
Can J Gastroenterol Hepatol; 2019; 2019():5121574. PubMed ID: 31687367
[TBL] [Abstract][Full Text] [Related]
16. Potential screening indicators for early diagnosis of NAFLD/MAFLD and liver fibrosis: Triglyceride glucose index-related parameters.
Xue Y; Xu J; Li M; Gao Y
Front Endocrinol (Lausanne); 2022; 13():951689. PubMed ID: 36120429
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the Triglyceride Glucose Index and Modified Triglyceride Glucose Indices to Predict Nonalcoholic Fatty Liver Disease in Youths.
Song K; Park G; Lee HS; Lee M; Lee HI; Choi HS; Suh J; Kwon A; Kim HS; Chae HW
J Pediatr; 2022 Mar; 242():79-85.e1. PubMed ID: 34808224
[TBL] [Abstract][Full Text] [Related]
18. Relationship Between Six Insulin Resistance Surrogates and Nonalcoholic Fatty Liver Disease Among Older Adults: A Cross-Sectional Study.
Li H; Shi Z; Chen X; Wang J; Ding J; Geng S; Sheng X; Shi S
Diabetes Metab Syndr Obes; 2023; 16():1685-1696. PubMed ID: 37309507
[TBL] [Abstract][Full Text] [Related]
19. A longitudinal epidemiological study on the triglyceride and glucose index and the incident nonalcoholic fatty liver disease.
Zheng R; Du Z; Wang M; Mao Y; Mao W
Lipids Health Dis; 2018 Nov; 17(1):262. PubMed ID: 30458848
[TBL] [Abstract][Full Text] [Related]
20. Triglyceride glucose-waist to height ratio: a novel and effective marker for identifying hepatic steatosis in individuals with type 2 diabetes mellitus.
Malek M; Khamseh ME; Chehrehgosha H; Nobarani S; Alaei-Shahmiri F
Endocrine; 2021 Dec; 74(3):538-545. PubMed ID: 34355342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]